Fragasso Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Sell
22,006
-780
-3% -$20.4K 0.03% 213
2026
Q1
$634K Sell
22,786
-470
-2% -$12.5K 0.04% 177
2025
Q4
$579K Buy
23,256
+2
+0% +$50 0.04% 184
2025
Q3
$636K Buy
23,254
+794
+4% +$19.6K 0.04% 164
2025
Q2
$544K Buy
22,460
+480
+2% +$11.2K 0.04% 179
2025
Q1
$557K Sell
21,980
-1,010
-4% -$26.4K 0.04% 164
2024
Q4
$610K Buy
22,990
+286
+1% +$7.76K 0.05% 152
2024
Q3
$657K Sell
22,704
-6,640
-23% -$194K 0.05% 148
2024
Q2
$821K Sell
29,344
-6,817
-19% -$188K 0.07% 130
2024
Q1
$1M Sell
36,161
-1,321
-4% -$36.7K 0.08% 118
2023
Q4
$1.08M Buy
37,482
+1,171
+3% +$35.4K 0.1% 107
2023
Q3
$1.2M Sell
36,311
-3,471
-9% -$123K 0.13% 95
2023
Q2
$1.46M Buy
39,782
+348
+0.9% +$13.5K 0.16% 90
2023
Q1
$1.61M Sell
39,434
-660
-2% -$28.5K 0.18% 70
2022
Q4
$2.05M Sell
40,094
-808
-2% -$38.7K 0.24% 60
2022
Q3
$1.79M Sell
40,902
-2,694
-6% -$131K 0.25% 49
2022
Q2
$2.29M Buy
43,596
+880
+2% +$44.8K 0.31% 49
2022
Q1
$2.21M Sell
42,716
-1,170
-3% -$60.7K 0.26% 51
2021
Q4
$2.59M Sell
43,886
-3,711
-8% -$184K 0.31% 49
2021
Q3
$2.05M Sell
47,597
-43,650
-48% -$1.93M 0.27% 52
2021
Q2
$3.57M Sell
91,247
-39,467
-30% -$1.53M 0.48% 47
2021
Q1
$4.74M Buy
130,714
+10,296
+9% +$366K 0.67% 39
2020
Q4
$4.43M Buy
120,418
+9,934
+9% +$364K 0.66% 36
2020
Q3
$3.85M Buy
110,484
+3,367
+3% +$118K 0.64% 40
2020
Q2
$3.91M Buy
107,117
+12,590
+13% +$428K 0.66% 39
2020
Q1
$2.93M Buy
94,527
+4,735
+5% +$161K 0.66% 37
2019
Q4
$3.34M Buy
89,792
+4,738
+6% +$169K 0.56% 47
2019
Q3
$2.9M Buy
85,054
+3,500
+4% +$127K 0.54% 48
2019
Q2
$3.35M Buy
81,554
+4,961
+6% +$197K 0.66% 40
2019
Q1
$3.09M Buy
76,593
+15,175
+25% +$608K 0.66% 35
2018
Q4
$2.54M Sell
61,418
-697
-1% -$28.9K 0.57% 29
2018
Q3
$2.6M Buy
62,115
+6,917
+13% +$266K 0.63% 24
2018
Q2
$1.9M Buy
55,198
+97
+0.2% +$3.31K 0.49% 29
2018
Q1
$1.85M Sell
55,101
-233
-0.4% -$8.01K 0.46% 26
2017
Q4
$1.9M Buy
55,334
+5,295
+11% +$181K 0.46% 29
2017
Q3
$1.7M Sell
50,039
-2,871
-5% -$92.3K 0.51% 23
2017
Q2
$1.69M Buy
52,910
+1,191
+2% +$37.6K 0.51% 24
2017
Q1
$1.68M Buy
51,719
+2,995
+6% +$94.4K 0.53% 24
2016
Q4
$1.5M Buy
48,724
+3,773
+8% +$115K 0.5% 29
2016
Q3
$1.44M Buy
44,951
+2,080
+5% +$69.5K 0.52% 23
2016
Q2
$1.43M Buy
42,871
+711
+2% +$22.7K 0.54% 19
2016
Q1
$1.19M Sell
42,160
-579
-1% -$16.5K 0.47% 31
2015
Q4
$1.31M Buy
42,739
+798
+2% +$25.1K 0.5% 27
2015
Q3
$1.25M Sell
41,941
-75
-0.2% -$2.4K 0.49% 27
2015
Q2
$1.34M Sell
42,016
-164
-0.4% -$5.34K 0.55% 16
2015
Q1
$1.39M Buy
42,180
+527
+1% +$16.8K 0.55% 21
2014
Q4
$1.23M Sell
41,653
-86
-0.2% -$2.47K 1.04% 24
2014
Q3
$1.17M Buy
41,739
+342
+0.8% +$9.6K 0.91% 25
2014
Q2
$1.17M Buy
41,397
+1,617
+4% +$46.1K 1.03% 23
2014
Q1
$1.21M Buy
39,780
+474
+1% +$14.1K 1.25% 16
2013
Q4
$1.14M Buy
+39,306
New +$1.14M 1.02% 20

Other funds holding PFE

Fragasso Financial Advisors's PFE Position: Q2 2026 in Review

Fragasso Financial Advisors reduced its Pfizer (PFE) stake by 3.4% in Q2 2026, selling an estimated $20.4K and leaving 22,006 shares worth $530K. The position accounts for 0.03% of the portfolio, ranked #213.

Fragasso Financial Advisors first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $4.74M in Q1 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fragasso Financial Advisors held 22,006 shares of Pfizer worth $530K as of Q2 2026.
  • Fragasso Financial Advisors sold 780 Pfizer shares in Q2 2026, an estimated $20.4K.
  • Pfizer made up 0.03% of Fragasso Financial Advisors's portfolio in Q2 2026, its #213 holding.
  • Fragasso Financial Advisors first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • Fragasso Financial Advisors's Pfizer position peaked at $4.74M in Q1 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.